Title: CLINICAL AND DIAGNOSTIC PARALLELS OF POSTACNE MANIFESTATIONS
Author: Кондакова
Last saved by: Nancy

DIAGNOSTIC CRITERIA AND THE TREATMENT OF GRANULOMATOUS ROSACEA
About the author: | L.D. Kaljuzhna, A.V. Petrenko, L.V. Hrechanska
Heading | clinical cases
Type of article | Scientific Article

Annotation

The article presents a case of rosacea in a36-year-old man with skin lesions in 
the form of erythema in the central part of the face, telangiectasia, phymatous 
growths on the forehead and glabella. Differential diagnosis was made between 
skin lymphoma, lupus erythematosus, Morbigan disease, fulminant acne, and 
granulomatous rosacea. Treatment was carried out using doxycycline and Ilon

Tags | rosacea, phyma, lupus erythematosis, lymphoma, Ilon.

Bibliography

1. Layton AM, Dreno B, Golinick HP, Zouboulis CC. A review of the European 
Directive for prescribing systemic isotretinoin for acne vulgaris. Journal of the 
European Academy of Dermatology and Venereology. 2006;20;7:773–776.
2. Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology 
of rosacea in the UK. Br J Dermatol. 2012;167:598–605.
3. Renieri G, Brochhausen C, Pfeiffer N, Pitz S. Chronic eyelid oedema and 
rosacea (Morbus Morbigan): diagnostic and therapeutic challenges. Klin Monbl 
Augenheilkd. 2011;228:19–24.
4. Kyriakis KP, Palamaras I, Terzoudi S, Emmanuelidis S, Michailidis C, Pagana 
G Epidemiologic aspects of rosacea. J Am Acad Dermatol. 2005;53:918–919.
5. Goldberg DJ, Berlin AL. Acne and rosacea: epidemiology, diagnosis and 
treatment. Maison publishing, 2012. 96 p.
6. Khokhar O, Khachemoune A. A case of granulomatous rosacea: sorting 
granulomatous rosacea from other granulomatous diseases that affect the face. 
Dermatol Online J. 2004;10:6.
7. Vemuri RC, Gundamuraju R, Secaran SD, Manikam R. Major 
pathophysiological correlations of rosacea: a complete clinical apprasal. Int J 
Med Sci. 2015;12:387–396.
8. Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens
stimulate inflammatory cells in rosacea. Br J Dermatol. 2007;157:800–805.
9. Plewig G, Kligman A. Acne and Rosacea. 2nd ed. Springer-Verlag, 
Berlin-New-York. 1993. 726 p.
10. Powell FC. The histopathology of rosacea: ‘Where’s the Beet?’. Dermatology. 
2004;209:173–174.
11. Rallis E, Korfitis C. Isotretinin for the treatment of granulomatous rosacea: 
case report and review of the literature. J Cuta Med Surg. 2012;16:438–441.
12. Schaller M, Ameida L, Bewley A, et al. Rosacea treatment update: 
Recommendations from the global Rosacea consensus (ROSCO) panel. Br J 
Dermatol. 2017;176:465–471.
13. Steinhoff M, Schmelz M, Schauder J. Facial erythema of rosacea –  
aetiology, different pathophysiologies and treatment options. Acta Derm 
Venereol. 2016;96:579–586.
14. Arzengruber F, Czernielewski J, Conrad C, Feldmeyer L, Yamalkar N, et al. 
Swiss S1 guidline for the treatment of rosacea. Journ Eur Acad Dermat Vener. 
2017;31:1775–1791.

Publication of the article

«DERMATOLOGY AND VENEREOLOGY» №3(93), 2021 year, 28-30 pages,
 index UDK 616.5–002.3–085.33

DOI | DOI: 10.33743/2308-1066-2021-3-28-30